Other languages Selvita S.A.

Equities

SLV

PLSLVCR00029

Delayed Warsaw S.E. Other stock markets 08:34:41 30/04/2024 BST			5-day change	1st Jan Change
68.2 ^PLN	+0.29%		-2.01%	+16.75%

03-28	Selvita S.A. agreed to acquire PozLab sp. z o.o.	CI
03-27	Selvita S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Selvita S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	03-26
Selvita S.A. Launches Biologic Drug Discovery and Development Services	03-18
Selvita S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-15
Selvita S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	27/09/23
The University of Oxford and Selvita Collaborate to Advance Potential Therapeutics for Parkinson's Disease	05/06/23
Selvita S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	30/05/23
Selvita schließt sich dem IND Package Pipeline Program von Scientist.com an	28/03/23
Selvita S.A. Continues to Scale its Operations with the Completion of New Research Centre	27/03/23
Selvita S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	14/01/23
Selvita S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	09/11/22
Selvita S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/09/22
Selvita S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/09/22
Selvita S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	30/05/22
Selvita S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	31/03/22
Immagene B.V. and Selvita Announce Integrated Drug Discovery Cooperation	07/02/22
Selvita Announces Management Changes	01/02/22
Selvita S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	24/11/21
Selvita S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021	22/09/21
Selvita Reports Earnings Results for the First Quarter 2021	26/05/21
Mabion S A : Big pharma and private equity seek healthy returns in Europe's east	20/05/21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Selvita S.A.

Equities

SLV

PLSLVCR00029

Other languages

Filters